MCLR — Medclair AB Income Statement
0.000.00%
Last trade - 00:00- SEK206.23m
- SEK202.67m
- SEK32.20m
Annual income statement for Medclair AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | ARS | ARS | ARS | ARS |
| Standards: | — | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.33 | 10.7 | 24.9 | 39.9 | 32.2 |
| Cost of Revenue | |||||
| Gross Profit | 4.26 | 7.52 | 20.4 | 24.8 | 23.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.23 | 23.6 | 29.8 | 42.5 | 38.3 |
| Operating Profit | -1.9 | -12.9 | -4.91 | -2.61 | -6.05 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.01 | -13 | -4.99 | -2.77 | -0.664 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.01 | -13 | -5 | -2.79 | -0.664 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.01 | -13 | -5 | -2.79 | -0.664 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.01 | -13 | -5 | -2.79 | -0.664 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.1 | -0.14 | -0.06 | -0.03 | -0.008 |
| Dividends per Share |